U.S. Global Investors (USGI)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,800
Closed -$455K 125
2017
Q3
$455K Buy
6,800
+189
+3% +$13.4K 0.14% 110
2017
Q2
$515K Sell
6,611
-289
-4% -$21.8K 0.18% 94
2017
Q1
$563 Sell
6,900
-430
-6% -$33.8K ﹤0.01% 90
2016
Q4
$528K Buy
7,330
+1,600
+28% +$116K 0.22% 91
2016
Q3
$445K Sell
5,730
-1,300
-18% -$105K 0.21% 103
2016
Q2
$548K Buy
7,030
+2,400
+52% +$191K 0.3% 101
2016
Q1
$379K Buy
+4,630
New +$376K 0.2% 122
2015
Q3
Sell
-2,700
Closed -$226K 297
2015
Q2
$226K Buy
+2,700
New +$238K 0.09% 202
2014
Q2
Sell
-4,400
Closed -$308K 302
2014
Q1
$308K Hold
4,400
0.05% 203
2013
Q4
$294K Sell
4,400
-1,410
-24% -$86.2K 0.05% 199
2013
Q3
$303K Buy
5,810
+810
+16% +$41.1K 0.05% 183
2013
Q2
$236K Buy
+5,000
New +$228K 0.04% 197

Other funds holding CAH

U.S. Global Investors (USGI)'s CAH Position: Q4 2017 in Review

U.S. Global Investors (USGI) sold out of Cardinal Health (CAH) in Q4 2017, closing a stake of 6,800 shares — an estimated $455K sold.

U.S. Global Investors (USGI) first reported a position in CAH in Q2 2013 and held it in 12 quarters. The position peaked at $548K in Q2 2016. 722 funds tracked by Wall St. Rank hold CAH as of Q4 2017.

  • U.S. Global Investors (USGI) reported no remaining Cardinal Health position as of Q4 2017 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 6,800 Cardinal Health shares in Q4 2017, an estimated $455K.
  • U.S. Global Investors (USGI) first reported a position in Cardinal Health in Q2 2013 and held it in 12 quarters.
  • U.S. Global Investors (USGI)'s Cardinal Health position peaked at $548K in Q2 2016.
  • 722 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2017.

Based on U.S. Global Investors (USGI)'s 13F filing for Q4 2017, filed 13 Feb 2018.